CAR T cells in marginal zone lymphoma (MZL) models with acquired resistance to PI3K and BTK inhibitors. (October 2022) - Wang, S.; Arribas, A.J.; Tarantelli, C.; Pradier, A.; Zucca, E.; Rossi, D.; Simonetta, F.; Bertoni, F.